Literature DB >> 11282807

How antidepressants work: new perspectives on the pathophysiology of depressive disorder.

I C Reid1, C A Stewart.   

Abstract

BACKGROUND: New research in animals is beginning to change radically our understanding of the biology of stress and the effects of antidepressant agents. AIMS: To relate recent findings from the basic neurosciences to the pathophysiology of depressive disorder.
METHOD: Drawing together findings from molecular and physiological studies in rats, social studies in primates and neuropsychological studies in humans, we review the neurotrophic and neuroplastic effects of antidepressants and stress.
RESULTS: Stress and antidepressants have reciprocal actions on neuronal growth and vulnerability (mediated by the expression of neurotrophins) and synaptic plasticity (mediated by excitatory amino acid neurotransmission) in the hippocampus and other brain structures. Stressors have the capacity to progressively disrupt both the activities of individual cells and the operating characteristics of networks of neurons throughout the life cycle, while antidepressant treatments act to reverse such injurious effects.
CONCLUSIONS: We propose a central role for the regulation of synaptic connectivity in the pathophysiology of depressive disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282807     DOI: 10.1192/bjp.178.4.299

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Cognitive prescriptions.

Authors:  David E Vance; Greg Eagerton; Brenna Harnish; Peggy McKie; Pariya L Fazeli
Journal:  J Gerontol Nurs       Date:  2010-12-22       Impact factor: 1.254

2.  Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study.

Authors:  Brendon P Boot; Bradley F Boeve; Rosebud O Roberts; Tanis J Ferman; Yonas E Geda; V Shane Pankratz; Robert J Ivnik; Glenn E Smith; Eric McDade; Teresa J H Christianson; David S Knopman; Eric G Tangalos; Michael H Silber; Ronald C Petersen
Journal:  Ann Neurol       Date:  2012-01       Impact factor: 10.422

Review 3.  Brain plasticity and antidepressant treatments: new cells, new connections.

Authors:  Ian C Reid; Caroline A Stewart
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Onset of action of antidepressants.

Authors:  Andre Tylee; Paul Walters
Journal:  BMJ       Date:  2007-05-05

Review 5.  Therapeutic Efficacy of Neurostimulation for Depression: Techniques, Current Modalities, and Future Challenges.

Authors:  Hafsah Akhtar; Faiza Bukhari; Misbah Nazir; Muhammad Nabeel Anwar; Adeeb Shahzad
Journal:  Neurosci Bull       Date:  2016-01-19       Impact factor: 5.203

6.  The role of hippocampal atrophy in depression: a neurocomputational approach.

Authors:  Victoria B Gradin; Andrés Pomi
Journal:  J Biol Phys       Date:  2008-07-30       Impact factor: 1.365

7.  Homeostatic cAMP regulation by the RGS7 complex controls depression-related behaviors.

Authors:  Cesare Orlandi; Laurie P Sutton; Brian S Muntean; Chenghui Song; Kirill A Martemyanov
Journal:  Neuropsychopharmacology       Date:  2018-10-11       Impact factor: 7.853

Review 8.  Trends in the development of new antidepressants. Is there a light at the end of the tunnel?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Med Chem       Date:  2004-04       Impact factor: 4.530

9.  Baldness : a diagnostic physical trait in mood disorders - sarvada sign.

Authors:  S C Tiwari; Sarvesh Singh
Journal:  Indian J Psychiatry       Date:  2004-10       Impact factor: 1.759

Review 10.  Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection.

Authors:  Eero Castrén
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.